CCKAR is a biomarker for prognosis and asynchronous brain metastasis of non-small cell lung cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Nan,Liang ^[1] ; Suohui,Sun ^[1] ; Zheng,Li ^[1] ; Tao,Wu ^[1] ; Chunpu,Zhang ^[1] ; Tao,Xin ^[2]

作者单位： Department of Neurosurgery, the Second Affiliated Hospital of Shandong First Medical University, Jinan, China. ^[1] Department of Neurosurgery, the First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China. ^[2]

关键词 Biomarker CCKAR brain metastasis non-small cell lung cancer prognosis

DOI 10.3389/fonc.2022.1098728

PMID 36733361

发布时间 2023-02-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2022年12卷

1098728页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

CCKAR is a biomarker for prognosis and asynchronous brain metastasis of non-small cell lung cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

CCKAR is a biomarker for prognosis and asynchronous brain metastasis of non-small cell lung cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除